Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors. Minakawa F, Yanagida N, Sugiyama S, Toi Y, et al. Eur J Dermatol 2025;35:224-229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Minakawa F, Yanagida N, Sugiyama S, Toi Y, et al. Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors. Eur J Dermatol 2025;35:224-229.
PMID: 40742060